Thiais, France

Florence Mahé

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Allergan, Inc.. Active years: 2011.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Florence Mahé in Ophthalmic Treatments.

Introduction

Florence Mahé is a notable inventor based in Thiais, France. She has made significant contributions to the field of ophthalmology through her innovative research and development. Her work focuses on the treatment of ocular disorders, showcasing her dedication to improving patient outcomes.

Latest Patents

Florence Mahé holds a patent for "Compositions and methods for the treatment of ophthalmic disease." This patent specifically addresses compositions and methods of treating ocular disorders that comprise CXCR4 inhibitory compositions. Her innovative approach has the potential to enhance therapeutic options for patients suffering from various eye conditions.

Career Highlights

Florence Mahé is currently associated with Allergan, Inc., a leading company in the pharmaceutical industry known for its focus on eye care products. Her role at Allergan has allowed her to further her research and contribute to the development of effective treatments for ophthalmic diseases.

Collaborations

Throughout her career, Florence has collaborated with esteemed colleagues such as Gerard Rodrigues and John E. Donello. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of ophthalmology.

Conclusion

Florence Mahé's contributions to ophthalmic treatments through her patent and work at Allergan, Inc. highlight her commitment to advancing medical science. Her innovative spirit and collaborative efforts continue to pave the way for new solutions in the treatment of ocular disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…